Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with TRDA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
TRDA
Entrada Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,418.01
▲
+0.03%
· post 1,412.00
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
TRDA
Entrada Therapeutics, Inc.
Change
5.11
▲
+12.65%
· post 5.08
Closed
Nov 2 '26
Mkt cap
$176.6M
Revenue
$898,000
Q2 FY26
Revenue
$25M
FY25
vs
Compare
Closed
Nov 2 '26
LLY
ELI Lilly & Co
vs
TRDA
Entrada Therapeutics, Inc.
1,418.01
▲
+0.03%
post 1,412.00
Price
5.11
▲
+12.65%
post 5.08
$1.3T
Mkt cap
$176.6M
Q3 FY26
$24.4B
Revenue
$898,000
Q2 FY26
FY25
$65.2B
Revenue
$25M
FY25
Change
Change
LLY
1,418.01
▲
+0.03%
vs
TRDA
5.11
▲
+12.65%
Closed
Nov 2 '26
Earnings history
last 4 reports each · paired by recency
Method
›
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
TRDA
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±56.7%
▼
−2.49%
×0.04
May 7 '26
±24.3%
▼
−57.27%
×2.36
= implied
LLY realized, solid
TRDA realized, hatched
One scale, both sides: full bar = 58%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±38.0%
▲
+6.76%
×0.18
Jan 8 '26
±42.8%
▼
−2.14%
×0.05